Visudyne gets EU green light
This article was originally published in Clinica
Executive Summary
The European Commission has approved Visudyne for the treatment of the wet form of age-related macular degeneration (AMD) in the EU, following the recommendation of the Committee for Proprietary Medicinal Products (CPMP).